Fraunhofer ITEM: Successful Testing of New Drug for Allergic Asthma – Business Wire (press release)

Fraunhofer ITEM: Successful Testing of New Drug for Allergic Asthma
Business Wire (press release)
Preparing lung function measurement by body plethysmography at the Fraunhofer ITEM: Inhaled treatment with the new drug “SB010”, developed by sterna biologicals, significantly improved lung function in patients with asthma. (Photo: Business Wire) …

View full post on asthma – Google News

Abbott to Develop CDx for AstraZeneca Asthma Drug – GenomeWeb

Abbott to Develop CDx for AstraZeneca Asthma Drug
GenomeWeb
NEW YORK (GenomeWeb) – AstraZeneca has inked an agreement with Abbott to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the investigational therapy, tralokinumab, developed by …
AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma PatientsStreetInsider.com
Diagnostic Tests for Biologic Asthma Therapy Under DevelopmentPharmacy Times
Drugmaker dives into personalized medicine for asthma, heart diseaseHealthcare Packaging
Cambridge News –London South East
all 8 news articles »

View full post on asthma – Google News

Progress Towards a New Asthma Treatment – Drug Discovery & Development


Drug Discovery & Development

Progress Towards a New Asthma Treatment
Drug Discovery & Development
Source: University of Queensland University of Queensland researchers are developing a new asthma treatment that targets the underlying cause of asthma, rather than just the symptoms. Asthma affects one in 10 Australians and is the most common chronic …

and more »

View full post on asthma – Google News

FDA approves Glaxo, Theravance’s Breo Ellipta asthma drug – Fox News


Fox News

FDA approves Glaxo, Theravance's Breo Ellipta asthma drug
Fox News
The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger asthma …
GlaxoSmithKline And Theravance: The Asthma Approval In FiguresSeeking Alpha
GlaxoSmithKline plc (ADR) Gets FDA Approval For Breo Ellipta To Treat Asthma Bidness ETC
FDA Okays Breo Ellipta for Asthma in AdultsMedscape
Bloomberg
all 81 news articles »

View full post on asthma – Google News

US FDA approves Glaxo, Theravance’s Breo Ellipta asthma drug – Reuters


Reuters

US FDA approves Glaxo, Theravance's Breo Ellipta asthma drug
Reuters
(Reuters) – The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger …
GlaxoSmithKline plc (ADR) Gets FDA Approval For Breo Ellipta To Treat Asthma Bidness ETC
FDA Okays Breo Ellipta for Asthma in AdultsMedscape
Glaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloomberg
WRAL Tech Wire
all 65 news articles »

View full post on asthma – Google News

FDA approves Glaxo, Theravance’s Breo Ellipta asthma drug – Reuters


Reuters

FDA approves Glaxo, Theravance's Breo Ellipta asthma drug
Reuters
(Reuters) – The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger …
Glaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloomberg
FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the USMarketWatch
FDA Okays Breo Ellipta for Asthma in AdultsMedscape
StreetInsider.com –CNNMoney –HCPLive
all 23 news articles »

View full post on asthma – Google News